Natalia Cernei

Natalia Cernei

Auto-generated profile, based on publicly available information

Natalia Cernei

IMSP Institutul de Medicină Urgentă; IP Universitatea de Stat de Medicină și Farmacie “Nicolae Testemițanu

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in Moldovan Journal of Health Sciences
Verified
Journal Article
Closed access
NCNatalia Cernei
Natalia Cernei
SSSerghei Sandru
Serghei Sandru
SCSerghei Cobilețchi
Serghei Cobilețchi
IGIon Grabovschi
Ion Grabovschi
ICIvan Civirjic
Ivan Civirjic
RBRuslan Baltaga
Ruslan Baltaga
Introduction. Oxygen-ozone therapy stands as a medically endorsed practice confirmed by numerous international clinical studies. Various authors have illustrated the beneficial clinical outcomes of ozone therapy in terms of its capacity to regulate redox balance, cellular inflammatory responses, and adaptation to ischemia/reperfusion processes. Ozone therapy extends to encompass a range of viral infections, inflammatory disorders, and degenerative ailments, used as both monotherapy and as an adjunct to unified conventional therapies. Material and methods. Narrative literature review study. Bibliographic search was conducted using the PubMed, Hinari, and SpringerLink databases, as well as the National Center of Biotechnology Information and Medline. Articles published between 1990 and 2022 were selected using various combinations of keywords, including “ozone”, “ozone therapy”, “mechanisms of ozone action”, “biological effects of ozone”, “antioxidant effect”, “anti-inflammatory effect” and “immunomodulatory effect.” Information regarding ozone’s mechanisms of action was identified and processed. Following the database information processing and search criteria, a total of 475 full-text articles were found. The final bibliography consists of 52 relevant sources that were deemed representative of the materials published on the topic of this synthesis article. Results. The effects of ozone on oxygen metabolism are explained by changes in the rheological properties of blood, including inhibition of erythrocyte aggregation and stimulation of 2,3-diphosphoglycerate in erythrocytes, favoring the transport and delivery of oxygen to tissues while facilitating the substantial elimination of nitric oxide and increasing blood flow. Intracellular triatomic oxygen enhances the oxidative carboxylation of pyruvate, stimulating ATP production, which also contributes to reducing peripheral vascular resistance. Conclusions. Ozone generates a moderate oxidative stress. Yet, it can set off several beneficial biochemical mechanisms that reactivate both the intra- and extracellular antioxidant systems and reverse chronic oxidative stress in various inflammatory and degenerative processes. Ozone induces a mild activation of the immune system by triggering neutrophil activation and stimulating the synthesis of certain cytokines (IL-2, TNF-α, IL-6, and IFN-γ), thereby initiating a complete cascade of immune responses. Ozone therapy yields the following biological reactions: optimization of blood circulation and oxygen delivery to ischemic tissue, regulation of cellular antioxidant enzymes, initiation of a slight immune system activation, and enhancing the release of growth factors.

1 April 2024 in Moldovan Journal of Health Sciences
Verified
Journal Article
Closed access
ICIvan Civirjic
Ivan Civirjic
ANAlina Nerpii
Alina Nerpii
NSNatalia Stefantov
Natalia Stefantov
IVIna Voleac
Ina Voleac
NCNatalia Cernei
Natalia Cernei
SSSerghei Sandru
Serghei Sandru
Ntroduction. During COVID-19 pandemic, non-invasive ventilation (NIV) was widely used during COVID-19 Pandemic. The factors predicting NIV failure in COVID-19 patients remain debatable. The goal of this research is to identify the parameters that may correlate NIV failure. Materials and methods. A retrospective analysis of COVID-19 patients’ data, who were admitted to ICU of the Institute of Emergency Medicine, Chisinau, during July-October 2020 and connected to NIV. The study analyzed the demographics, laboratory and respiratory parameters (at admission, at NIV initiation, 24-48h and 72-96h of NIV) and their relation with NIV failure. . For continuous variables, the established confidence interval was 95%. The Kruskal-Wallis H test was used for continuous variables and the Fisher’s exact test or chi-squared test was used for category data. Results. In study were included 154 patients. NIV failed in 52 patients. In NIV failure group were registered a higher rate of hypertension (88% vs 74%, p = 0.033), delirium (60% vs 20%, p=0.001) and need for sedation (83% vs 48, p=0.001). The urea levels were lower in NIV success group at admission, at NIV initiation and at 24-48h of NIV. The neutrophil/ lymphocyte ratio was higher in NIV failure group at NIV initiation; at 24-48h and 72-96h of NIV. NIV failure group had a higher level of WBC count and C-reactive protein at 24-48h and 72-96h as well as D-dimer at 72-96h of NIV. The ROX index was higher in NIV success group from NIV initiation and through 72h of NIV. Conclusions. The presence of abnormal values of neutrophil/lymphocyte ratio, urea, lymphocytes, WBC count, C-reactive protein, D-dimer and ROX index during non-invasive ventilation, as well as association of delirium and need for sedation, can be suggestive and informative for high risk of NIV failure in COVID-19 patients. Continuous measurement of these parameters may help the clinicians to decide the optimal timing of conversion to invasive ventilation.

1 December 2023 in Moldovan Journal of Health Sciences
Verified
Journal Article
Closed access
OGOlga Gherasim
Olga Gherasim
DCDumitru Casian
Dumitru Casian
ICIvan Civirjic
Ivan Civirjic
NCNatalia Cernei
Natalia Cernei
SSSerghei Sandru
Serghei Sandru
Introduction. Evaluation of patient volemia arriving at a medical service today still represents a challenge for specialists, especially in those who need surgical and anesthetic intervention. One of the most common systemic side effect to anesthesia is hypotension. Spinal Anesthesia-Induced Hypotension (SAIH) because of sympathetic blockade is most frequently cited as a complication of subarachnoid anesthesia, its severity being influenced by the patient’s volemic state. The aim of this literature review is to analyze if „routine” preanesthetic preloading reduces the incidence of SAIH in patients undergoing spinal anesthesia, also to emphasize the efficacy of preanesthetic assessment of the IVC/Ao (Inferior Vena Cava/ Abdominal Aorta) Index measured by ultrasound in determination of patients’ volemia. Material and methods. Narrative literature review. Bibliographic search in the PubMed, NCBI and Google Academic databases, using the keywords: „hypotension inferior vena cava”, „hypotension spinal anesthesia”, „inferior vena cava/aorta diameter”, „preloading hypotension”, which were combined with each other. The final bibliography included 40 references. Results. The principles of perianesthetic volemia management and prevention of arterial hypotension after the administration of the spinal block were detected in different groups of patients: the elderly, adult patients, anesthesiologic assistance in obstetrics and in various types of surgical interventions. Hypotension incidence data in patients with and without preanesthetic volume repletion were detected. At the same time, the effectiveness of the ultrasonographic assessment of IVC/Ao index in assessing patient’s volume status was determined. The information was analyzed and synthesized in the article. Conclusions. The effectiveness of routine preloading in reducing the incidence of arterial hypotension after spinal anesthesia did not prove its benefits in normovolemic patients, and ultrasonographic assessment of the IVC/Ao Index in assessing the volume status appears to be a simple, rapid, non-invasive, cost-effective volume assessment, which does not require the presence of a specialized imagist, being practically devoid of contraindications.

1 December 2022 in The Moldovan Medical Journal
Verified
Journal Article
Closed access
ICIvan Civirjic
Ivan Civirjic
SSSerghei Sandru
Serghei Sandru
AAArnaut Arnaut
Arnaut Arnaut
NCNatalia Cernei
Natalia Cernei
VMVictoria Moghildea
Victoria Moghildea
Background: Analysis and evaluation of the multitude of parameters that impact and mirror clinical evolution of COVID-19 infection. Narrative literature review type of study. Bibliographic search of the PubMed database, applying the keywords: ”SARS-CoV-2”, ”COVID-19”, ”risk score”, ”laboratory parameters”, ”pathophysiology”, ”cytokine storm”, ”imaging evaluation”, “outcomes”, “clinical evolution”, which were combined with each other. There were selected English-language publications, in extenso, published in recognized journals from March 2020. Priority in the analysis was given to articles of critical synthesis of literature, randomized studies, those with large samples of patients. One of the clinically important symptoms that reflects severe or critical clinical evolution is persistent fever during the time. The presence of comorbidities, especially associated with obesity, represents a high risk of severe evolution. Proinflammatory, prothrombotic and systemic endothelial damage processes are represented by changes in platelet count, lymphocytes, neutrophil / lymphocyte ratio, C-reactive protein, D-dimers, fibrinogen, procalcitonin, urea, creatinine, ALS, AST, interleukin-6 and serum ferritin. Bacterial and fungal infections negatively influence clinical evolution. Common prediction scores have low value in COVID-19 patients and need adaptation. Imaging evaluation identifies the type of lung injury and correlates with the severity degree and outcome. Conclusions: COVID-19 disease caused by SARS-CoV-2 virus includes a multitude of pathophysiological changes that through its mechanism represent a systemic nosology. The complete analysis of all the factors and parameters that can influence its clinical evolution is a basic component of the decision-making steps and treatment approach.

1 December 2024 in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
Verified
Journal Article
Open access
PDF file
NCNatalia Cernei
Natalia Cernei
Aim. Emphasising the particularities of clinical, laboratory parameters, and the treatment results of critical patients with COVID-19 in the Intensive Care Unit. Material and methods. Totally 100 patients with COVID-19 admitted to the Intensive Care Unit of the Institute of Emergency Medicine Results. The most common comorbidities were hypertension, diabetes mellitus and obesity. The frequency of application of Oxygen therapy was 74.0% of patients; of non-invasive ventilation was 73.0% while frequency of invasive mechanical ventilation was 30.0% of patients. Conclusions. The treatment protocols led to a significant reduction in CRP, hemoglobin and albumin levels and statistically increase of D-dimer, leukocyte, platelet, ESR, and ALT levels.

1 April 2023 in The Moldovan Medical Journal
Verified
Journal Article
Closed access
NCNatalia Cernei
Natalia Cernei
RBRuslan Baltaga
Ruslan Baltaga
SSSerghei Sandru
Serghei Sandru
AAArnaut Arnaut
Arnaut Arnaut
ICIvan Civirjic
Ivan Civirjic
OGOlga Gherasim
Olga Gherasim
Introduction: The recorded studies suggest that there is clear evidence-based association between various laboratory biomarkers and COVID-19 disease severity. These marker levels reflect the intensity of the cytokine-mediated hyperinflammatory response, which is strongly associated with a poor outcome of SARS-CoV-2 infection. Conclusions: C-reactive protein is not only a systemic inflammatory marker, but also an important regulator of inflammatory processes. The level of this protein is positively correlated and can be widely used to predict the severity, prognosis and mortality in COVID-19 patients, additionally to vital signs monitoring, supportive care, oxygen therapy, ventilation and circulatory support. Procalcitonin is an indicator of disease severity, which can facilitate timely clinical decision-making, and determination of procalcitonin levels during COVID-19 patients’ follow-up, as well as being used in assessing risk, predicting prognosis, and improving patient survival. The assessment of hematological laboratory parameters upon admission, which help in differentiating between severe and non-severe cases, high-risk and low-risk cases of mortality, allows raising awareness, monitoring and timely treatment of patients with COVID-19, as well as their early improvement of clinical condition. Inflammatory biochemical and hemocytometric measures are feasible, easily interpretable, and widely available biomarkers in most healthcare settings, favorable for being used in treatment and severity determination, in predicting clinical outcomes, and in the prognosis of patients with COVID-19. However, the assessment of the accuracy of these biomarkers needs to be determined in further more relevant worldwide studies, showing a more precise design, more accurate performance, and having larger sample sizes.